Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan F Rudy

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.
Journal of Voice : Official Journal of the Voice Foundation|December 13, 2006
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
American Journal of Rhinology|February 13, 2007
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
American Journal of Otolaryngology|December 13, 2006
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
Ear, Nose, & Throat Journal|January 24, 2007
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
Head & Neck|May 28, 2005
A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinomaColleen H Druzgal, Zhong Chen, Ning T Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancerAthanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunctionBruce J Baum, Ilias Alevizos, Changyu Zheng, et al.
Blood|May 20, 2009
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLaura A Johnson, Richard A Morgan, Mark E Dudley, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.
Journal of Voice : Official Journal of the Voice Foundation|December 13, 2006
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
American Journal of Rhinology|February 13, 2007
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
American Journal of Otolaryngology|December 13, 2006
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
Ear, Nose, & Throat Journal|January 24, 2007
Standards for ethical publicationJonas T Johnson, John K Niparko, Paul A Levine, et al.
Head & Neck|May 28, 2005
A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinomaColleen H Druzgal, Zhong Chen, Ning T Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancerAthanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunctionBruce J Baum, Ilias Alevizos, Changyu Zheng, et al.
Blood|May 20, 2009
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLaura A Johnson, Richard A Morgan, Mark E Dudley, et al.
Pageof 3